002370.SZ
亚太药业
SZSE · Healthcare · C 制造业 · CN
CNY 5.45
−3.71%Margins
Gross margin
33.9%
EBITDA margin
38.4%
EBIT margin
30.1%
Net margin
31.9%
FCF margin
2.7%
9.1%
Return on equity
8.2%
Return on assets
—
Return on invested capital
0.25x
Asset turnover
CNY 15.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026